4//SEC Filing
Xenon Pharmaceuticals Inc. 4
Accession 0001171843-15-006901
$XENECIK 0001582313operating
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 6:02 AM ET
Size
10.1 KB
Accession
0001171843-15-006901
Insider Transaction Report
Form 4
GOLDBERG Y. PAUL
VP of Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2015-12-18+15,000→ 15,000 totalExercise: $7.69Exp: 2025-12-17→ Common Shares (15,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on December 18, 2016, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001582313
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 6:02 AM ET
- Size
- 10.1 KB